Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

BNT162b2 mRNA COVID-19 Vaccine: First Approval
Yvette N. Lamb
Drugs (2021) Vol. 81, Iss. 4, pp. 495-501
Open Access | Times Cited: 341

Showing 26-50 of 341 citing articles:

Research progress on circular RNA vaccines
Yu Bai, Dong Liu, Qian He, et al.
Frontiers in Immunology (2023) Vol. 13
Open Access | Times Cited: 36
New insights from nanotechnology in SARS-CoV-2 detection, treatment strategy, and prevention
Raghu Solanki, Abhishek Shankar, Unnati Modi, et al.
Materials Today Chemistry (2023) Vol. 29, pp. 101478-101478
Open Access | Times Cited: 33
Enhanced adipose-derived stem cells with IGF-1-modified mRNA promote wound healing following corneal injury
Fei Yu, Danni Gong, Dan Yan, et al.
Molecular Therapy (2023) Vol. 31, Iss. 8, pp. 2454-2471
Closed Access | Times Cited: 33
Adjuvant physiochemistry and advanced nanotechnology for vaccine development
Hongze Ren, Wencong Jia, Yujie Xie, et al.
Chemical Society Reviews (2023) Vol. 52, Iss. 15, pp. 5172-5254
Closed Access | Times Cited: 33
Controlling lamellarity and physicochemical properties of liposomes prepared using a microfluidic device
Yuka Matsuura-Sawada, Masatoshi Maeki, Shuya Uno, et al.
Biomaterials Science (2023) Vol. 11, Iss. 7, pp. 2419-2426
Open Access | Times Cited: 24
Accelerated blood clearance of PEGylated nanoparticles induced by PEG-based pharmaceutical excipients
Guifeng Miao, Yuejian He, Keren Lai, et al.
Journal of Controlled Release (2023) Vol. 363, pp. 12-26
Closed Access | Times Cited: 22
COVID-19 Vaccines: Where Did We Stand at the End of 2023?
Kenneth Lundström
Viruses (2024) Vol. 16, Iss. 2, pp. 203-203
Open Access | Times Cited: 10
Vaccine adjuvants for infectious disease in the clinic
Morgan Goetz, Naaz Thotathil, Zongmin Zhao, et al.
Bioengineering & Translational Medicine (2024) Vol. 9, Iss. 4
Open Access | Times Cited: 10
Current Progress, Challenges and Prospects in the Development of COVID-19 Vaccines
Congrui Zhu, Shengmei Pang, Jiaqi Liu, et al.
Drugs (2024) Vol. 84, Iss. 4, pp. 403-423
Closed Access | Times Cited: 10
Pseudouridine and N1-methylpseudouridine as potent nucleotide analogues for RNA therapy and vaccine development
Lyana L. Y. Ho, Gabriel H. A. Schiess, Pâmella Miranda, et al.
RSC Chemical Biology (2024) Vol. 5, Iss. 5, pp. 418-425
Open Access | Times Cited: 9
Nucleic acid drugs: recent progress and future perspectives
Xiaoyi Sun, Sarra Setrerrahmane, Chencheng Li, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 9
Development of an ancestral DC and TLR4-inducing multi-epitope peptide vaccine against the spike protein of SARS-CoV and SARS-CoV-2 using the advanced immunoinformatics approaches
Cena Aram, Parsa Alijanizadeh, Kiarash Saleki, et al.
Biochemistry and Biophysics Reports (2024) Vol. 39, pp. 101745-101745
Open Access | Times Cited: 8
Recent advances in surface decoration of nanoparticles in drug delivery
Phuong-Dung Ly, Ky-Nhu Ly, Hoàng Long Phan, et al.
Frontiers in Nanotechnology (2024) Vol. 6
Open Access | Times Cited: 8
Expanding the Potential of Circular RNA (CircRNA) Vaccines: A Promising Therapeutic Approach
Tian Bu, Wenlong Yang, Jian Zhao, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 1, pp. 379-379
Open Access | Times Cited: 1
Delivery Routes for COVID-19 Vaccines
Jang Hyun Park, Heung Kyu Lee
Vaccines (2021) Vol. 9, Iss. 5, pp. 524-524
Open Access | Times Cited: 54
Self-Replicating RNA Viruses for Vaccine Development against Infectious Diseases and Cancer
Kenneth Lundström
Vaccines (2021) Vol. 9, Iss. 10, pp. 1187-1187
Open Access | Times Cited: 49
Efficacy of mRNA, adenoviral vector, and perfusion protein COVID-19 vaccines
Mohammad Reza Zinatizadeh, Peyman Kheirandish Zarandi, Maryam Zinatizadeh, et al.
Biomedicine & Pharmacotherapy (2021) Vol. 146, pp. 112527-112527
Open Access | Times Cited: 42
Association of total and neutralizing SARS-CoV-2 spike -receptor binding domain antibodies with epidemiological and clinical characteristics after immunization with the 1st and 2nd doses of the BNT162b2 vaccine
Athanasios Michos, Elizabeth‐Barbara Tatsi, Filippos Filippatos, et al.
Vaccine (2021) Vol. 39, Iss. 40, pp. 5963-5967
Open Access | Times Cited: 41
mRNA vaccines in the prevention and treatment of diseases
Yangzhuo Gu, Jiangyao Duan, Na Yang, et al.
MedComm (2022) Vol. 3, Iss. 3
Open Access | Times Cited: 35
An Overview of Rift Valley Fever Vaccine Development Strategies
Paul Kato Kitandwe, Paul F. McKay, Pontiano Kaleebu, et al.
Vaccines (2022) Vol. 10, Iss. 11, pp. 1794-1794
Open Access | Times Cited: 35
Use of analgesics/antipyretics in the management of symptoms associated with COVID-19 vaccination
Eng Eong Ooi, Arti Dhar, Richard A. Petruschke, et al.
npj Vaccines (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 30
Effect of the third dose of BNT162b2 vaccine on quantitative SARS-CoV-2 spike 1–2 IgG antibody titers in healthcare personnel
María Elena Romero-Ibarguengoitia, Diego Rivera-Salinas, Yodira Guadalupe Hernández-Ruíz, et al.
PLoS ONE (2022) Vol. 17, Iss. 3, pp. e0263942-e0263942
Open Access | Times Cited: 29
Immunogenicity mechanism of mRNA vaccines and their limitations in promoting adaptive protection against SARS-CoV-2
Mohd Zulkifli Salleh, Mohd Nor Norazmi, Zakuan Zainy Deris
PeerJ (2022) Vol. 10, pp. e13083-e13083
Open Access | Times Cited: 29
Clinical Severity of SARS-CoV-2 Variants during COVID-19 Vaccination: A Systematic Review and Meta-Analysis
Zhilu Yuan, Zengyang Shao, Lijia Ma, et al.
Viruses (2023) Vol. 15, Iss. 10, pp. 1994-1994
Open Access | Times Cited: 20
COVID-19 in Latin America: A Snapshot in Time and the Road Ahead
J LaRotta, Omar Escobar, María L. Ávila-Agüero, et al.
Infectious Diseases and Therapy (2023) Vol. 12, Iss. 2, pp. 389-410
Open Access | Times Cited: 19

Scroll to top